Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Coop

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Journal of Medicinal Chemistry|April 18, 2003
Synthesis and biological evaluation of 14-alkoxymorphinans. 18. N-substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: extending the scope of common structure-activity relationshipsElisabeth Greiner, Mariana Spetea, Roland Krassnig, et al.
Journal of Molecular Biology|July 8, 2008
Divalent metal ion complexes of S100B in the absence and presence of pentamidineThomas H Charpentier, Paul T Wilder, Melissa A Liriano, et al.
Psychopharmacology|June 29, 2005
Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and ratsWilliam E Fantegrossi, Andrew W Harrington, Justin R Eckler, et al.
Journal of Medicinal Chemistry|May 28, 2004
Synthesis and biological evaluation of 14-alkoxymorphinans. 21. Novel 4-alkoxy and 14-phenylpropoxy derivatives of the mu opioid receptor antagonist cyprodimeMariana Spetea, Falko Schüllner, Radu C Moisa, et al.
Biochemistry|May 28, 2009
Small molecules bound to unique sites in the target protein binding cleft of calcium-bound S100B as characterized by nuclear magnetic resonance and X-ray crystallographyThomas H Charpentier, Paul T Wilder, Melissa A Liriano, et al.
International Journal of High Throughput Screening|December 7, 2010
In vitro screening and structural characterization of inhibitors of the S100B-p53 interactionPaul T Wilder, Thomas H Charpentier, Melissa A Liriano, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 17, 2005
Novel gamma-hydroxybutyric acid (GHB) analogs share some, but not all, of the behavioral effects of GHB and GABAB receptor agonistsLawrence P Carter, Huifang Wu, Weibin Chen, et al.
Cancer Research|October 16, 2003
Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1/2 expression statusMatthew J Ellis, Andrew Coop, Baljit Singh, et al.
ACS Medicinal Chemistry Letters|December 25, 2012
Structure-Based Discovery of a Novel Pentamidine-Related Inhibitor of the Calcium-Binding Protein S100BLaura E McKnight, E Prabhu Raman, Padmavani Bezawada, et al.
Bioorganic & Medicinal Chemistry|December 12, 2001
CRHR1 Receptor binding and lipophilicity of pyrrolopyrimidines, potential nonpeptide corticotropin-releasing hormone type 1 receptor antagonistsLing-Wei Hsin, Xinrong Tian, Elizabeth L Webster, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Journal of Medicinal Chemistry|April 18, 2003
Synthesis and biological evaluation of 14-alkoxymorphinans. 18. N-substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: extending the scope of common structure-activity relationshipsElisabeth Greiner, Mariana Spetea, Roland Krassnig, et al.
Journal of Molecular Biology|July 8, 2008
Divalent metal ion complexes of S100B in the absence and presence of pentamidineThomas H Charpentier, Paul T Wilder, Melissa A Liriano, et al.
Psychopharmacology|June 29, 2005
Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and ratsWilliam E Fantegrossi, Andrew W Harrington, Justin R Eckler, et al.
Journal of Medicinal Chemistry|May 28, 2004
Synthesis and biological evaluation of 14-alkoxymorphinans. 21. Novel 4-alkoxy and 14-phenylpropoxy derivatives of the mu opioid receptor antagonist cyprodimeMariana Spetea, Falko Schüllner, Radu C Moisa, et al.
Biochemistry|May 28, 2009
Small molecules bound to unique sites in the target protein binding cleft of calcium-bound S100B as characterized by nuclear magnetic resonance and X-ray crystallographyThomas H Charpentier, Paul T Wilder, Melissa A Liriano, et al.
International Journal of High Throughput Screening|December 7, 2010
In vitro screening and structural characterization of inhibitors of the S100B-p53 interactionPaul T Wilder, Thomas H Charpentier, Melissa A Liriano, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 17, 2005
Novel gamma-hydroxybutyric acid (GHB) analogs share some, but not all, of the behavioral effects of GHB and GABAB receptor agonistsLawrence P Carter, Huifang Wu, Weibin Chen, et al.
Cancer Research|October 16, 2003
Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1/2 expression statusMatthew J Ellis, Andrew Coop, Baljit Singh, et al.
ACS Medicinal Chemistry Letters|December 25, 2012
Structure-Based Discovery of a Novel Pentamidine-Related Inhibitor of the Calcium-Binding Protein S100BLaura E McKnight, E Prabhu Raman, Padmavani Bezawada, et al.
Bioorganic & Medicinal Chemistry|December 12, 2001
CRHR1 Receptor binding and lipophilicity of pyrrolopyrimidines, potential nonpeptide corticotropin-releasing hormone type 1 receptor antagonistsLing-Wei Hsin, Xinrong Tian, Elizabeth L Webster, et al.
Pageof 10